pks+ Escherichia coli more prevalent in benign than malignant colorectal tumors

Mol Biol Rep. 2021 Jul;48(7):5451-5458. doi: 10.1007/s11033-021-06552-1. Epub 2021 Jul 23.

Abstract

Background: Some E. coli strains that synthesize the toxin colibactin within the 54-kb pks island are being implicated in colorectal cancer (CRC) development. Here, the prevalence of pks+ E. coli in malignant and benign colorectal tumors obtained from selected Filipino patients was compared to determine the association of pks+ E. coli with CRC in this population.

Methods and results: A realtime qPCR protocol was developed to quantify uidA, clbB, clbN, and clbA genes in formalin fixed paraffin embedded colorectal tissues. The number of malignant tumors (44/62; 71%) positive for the uidA gene was not significantly different (p = 0.3428) from benign (38/62; 61%) tumors. Significantly higher number of benign samples (p < 0.05) were positive for all three colibactin genes (clbB, clbN, and clbA) compared with malignant samples. There was also higher prevalence of pks+ E. coli among older females and in tissue samples taken from the rectum.

Conclusion: Hence, pks+ E. coli may not be associated with CRC development among Filipinos.

Keywords: clbA; clbB; clbN; colorectal cancer; pks + E. coli.

MeSH terms

  • Colorectal Neoplasms / diagnosis
  • Colorectal Neoplasms / etiology*
  • Disease Susceptibility*
  • Escherichia coli / genetics*
  • Escherichia coli Infections / complications*
  • Escherichia coli Infections / diagnosis
  • Escherichia coli Infections / microbiology*
  • Escherichia coli Proteins / genetics
  • Escherichia coli Proteins / metabolism
  • Humans
  • Neoplasm Grading
  • Neoplasm Staging
  • Peptides / genetics*
  • Peptides / metabolism
  • Polyketides / metabolism
  • Polymerase Chain Reaction

Substances

  • Escherichia coli Proteins
  • Peptides
  • Polyketides
  • colibactin